NDC 66689-005-01 - Hydrocodone Bitartrate and Acetaminophen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66689-005
- Requested NDC
- 66689-005-01
- Package NDCs from labels
- 66689-005-01, 66689-005-50
- Manufacturer
- VistaPharm, LLC
- Effective date
- 2024-07-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrocodone Bitartrate and Acetaminophen - VistaPharm, LLC | VistaPharm, LLC | 2024-07-11 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66689-005-50 | 2024-01-30 | C162847 | 48780-1 | 1030e365-0938-111a-e063-dadaa90a10e2 | Hydrocodone Bitartrate and Acetaminophen Oral Solution, CII |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66689-005-01 | ML - Milliliter | 66689-005 | 0047ce97-2c9b-4817-adc1-22461f69467e | 1 | 2019-07-02 |
| 66689-005-50 | ML - Milliliter | 66689-005 | 3bfc0e60-dde1-4375-abfe-cc156f1aae28 | 1 | 2019-07-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen | ACETAMINOPHEN | A-S Medication Solutions | c4f0f591-8501-4c6d-bf8e-ca3068ff65b5 | 2025-04-24 | Warnings | 362O9ITL9D |
| Extra Strength No-Pain | ACETAMINOPHEN | Safrel Pharmaceuticals, LLC. | 873f01dd-0701-5fd3-e053-2a95a90a6463 | 2025-04-23 | Warnings | 362O9ITL9D |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Kesin Pharma Corporation | 3140f8fe-0644-7561-e063-6394a90a2c28 | 2025-04-21 | Adverse reactions | XF417D3PSL |
| ADVIL DUAL ACTION WITH ACETAMINOPHEN | IBUPROFEN, ACETAMINOPHEN | Haleon US Holdings LLC | f5ea858e-76d9-4777-b3dc-5d614f66d485 | 2025-04-21 | Warnings | 362O9ITL9D |
| Pain Reliever | ACETAMINOPHEN | Chain Drug Consortium | 60d4b392-6ed0-4115-8154-24eaf72504a5 | 2025-04-16 | Warnings | 362O9ITL9D |
| OXYCODONE AND ACETAMINOPHEN | OXYCODONE AND ACETAMINOPHEN | Asclemed USA, Inc. | 71c7a627-6ed9-4f49-8cdc-b3228c021e64 | 2025-04-15 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| foster and thrive pain reliever | ACETAMINOPHEN | Strategic Sourcing Services LLC | 23780dab-91d8-434f-9342-f5f1ba0a3c0a | 2025-04-15 | Warnings | 362O9ITL9D |
| Premsyn pms Premenstrual Pain Relief | ACETAMINOPHEN AND PAMABROM AND PYRILAMINE MALEATE | Focus Consumer Healthcare, LLC | 5b6f6260-69ae-cfeb-e053-2a91aa0a6b49 | 2025-04-14 | Warnings | 362O9ITL9D |
| BackAid Max | ACETAMINOPHEN, PAMABROM | Kobayashi Healthcare International, Inc. | fb9a5647-b7c9-4820-b148-91060e34cb83 | 2025-04-14 | Warnings | 362O9ITL9D |
| Butalbital, Acetaminophen and Caffeine | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Aurolife Pharma, LLC | f9fde75d-7def-48fc-a2b0-727f677f6001 | 2025-04-14 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Arthriten Inflammatory Pain Formula | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Kobayashi Healthcare International, Inc | c280ca89-4fb5-4050-90ee-d706a550a1ef | 2025-04-11 | Warnings | 362O9ITL9D |
| Midol Complete | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | Bayer HealthCare LLC. | ce9e6acb-a38b-4c9b-a7e8-3e1c2a49a324 | 2025-04-10 | Warnings | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Redpharm drug | 1535f903-8bd0-c09e-e063-6294a90a4d4d | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | NO70W886KK 362O9ITL9D |
| Acetaminophen and Codeine | ACETAMINOPHEN AND CODEINE | RedPharm Drug, Inc. | a35b4ba3-43c0-73c8-e053-2a95a90af5b5 | 2025-04-09 | Boxed warning, Warnings | 362O9ITL9D |
| Bio Co Enzyme Phase | ACONITICUM ACIDUM, CIS-, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ADRENALINUM, , ALPHA-KETOGLUTARICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, ASCORBICUM ACIDUM, BARIUM OXALSUCCINICUM, BETA VULGARIS, CERIUM OXALICUM, CITRICUM ACIDUM, CYSTEINUM, FUMARICUM ACIDUM, HEPAR SULPHURIS CALCAREUM, MAGNESIUM OROTICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM PHOSPHORICUM, NADIDUM, NATRUM OXALACETICUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PANTOTHENIC ACID, PROTEUS (MORGANI), PULSATILLA (PRATENSIS), PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, | Deseret Biologicals, Inc. | 6edee6eb-0ec9-4d2a-9dc9-dc2a6503a6db | 2025-04-08 | Warnings | XF417D3PSL |
| Foster and Thrive Pain Reliever | ACETAMINOPHEN | Strategic Sourcing Services LLC | 0a7d82f8-7615-4cef-b245-94b186f3c8fa | 2025-04-07 | Warnings | 362O9ITL9D |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Direct_Rx | e4e27022-581e-ba8c-e053-2a95a90a1ae4 | 2025-04-07 | Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Gland Pharma Limited | db5d4cf8-762a-4111-971e-91c704bc3643 | 2025-04-04 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN 500MG | CVS Pharmacy, Inc. | 1fde6487-6682-99a3-e063-6294a90a3670 | 2025-04-04 | Warnings | 362O9ITL9D |
| Acetaminophen 250 mg and Ibuprofen 125 mg | ACETAMINOPHEN AND IBUPROFEN | Dr. Reddy's Labortories Inc | 3e65c8a3-498e-1a2a-bb76-18e28ae2c73c | 2025-04-04 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.